Status:
COMPLETED
Drug Use Investigation for Cervarix®
Lead Sponsor:
GlaxoSmithKline
Conditions:
Infections, Papillomavirus
Eligibility:
FEMALE
10+ years
Brief Summary
This post-marketing study was designed to assess safety and efficacy of Cervarix® vaccine in Japanese female subjects under conditions of actual use.
Eligibility Criteria
Inclusion
- Subject must be female
- Subject must be aged 10 and over
Exclusion
- Subject with obvious fever
- Subject with obvious severe acute disease
- Subject with hypersensitivity to any component of Cervarix®
- Other than above, subject who is in inappropriate conditions for vaccination
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
1230 Patients enrolled
Trial Details
Trial ID
NCT01187927
Start Date
September 1 2010
End Date
January 1 2014
Last Update
January 26 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.